Medical knowledge · Legal judgment · Human agency

Active LitigationUpdated 2025

Dangerous Drug Lawsuits

Explore lawsuits involving dangerous drugs, recalled medications, severe side effects, alleged failure-to-warn issues, and other pharmaceutical injury claims. MD Law's Dangerous Drugs hub is designed to help users understand which medications are currently in litigation, what injuries are being alleged, and where their own situation may fit.

Current claims evolve. Qualification depends on the drug, the injury, the timing, and the available proof.

Find Drug Litigation

Search by drug, injury, lawsuit, or claim type

What You'll Find in the Dangerous Drugs Section

Drug litigation can be difficult to navigate for obvious reasons. People are often prescribed medications they do not fully understand, develop complications that could have several causes, and only later discover that the product is being investigated or litigated. By then, records, timelines, warnings, and medical context all matter.

This section is built to make that clearer. Here you can explore:

  • active dangerous drug lawsuits
  • recalled drug claims
  • medication-specific litigation pages
  • pharmaceutical failure-to-warn issues
  • qualification and case-evaluation guidance
  • broader product liability resources tied to drug injury claims

This is not meant to be a panic machine. It is meant to be a structured entry point into a complex area where medicine, regulation, and litigation intersect.

Featured Dangerous Drug Lawsuits

View All Active Drug Lawsuits

Ozempic Lawsuit

Active Litigation

Current litigation includes allegations involving severe gastrointestinal injury and related complications associated with Ozempic and similar medications in some users.

Wegovy Lawsuit

Active Litigation

Claims involving Wegovy have drawn attention to similar alleged gastrointestinal injuries and broader questions about warnings, causation, and product liability.

Mounjaro Lawsuit

Active Litigation

Current claims involving Mounjaro and related GLP-1 drugs focus on alleged severe digestive injury and related harm in certain users.

Tepezza Hearing Loss Lawsuit

Active Litigation

Litigation has focused on allegations of serious or permanent hearing-related injury associated with Tepezza treatment.

Elmiron Eye Injury Lawsuit

Active Litigation

Claims involving Elmiron have centered on allegations of retinal or other vision-related injury associated with long-term use in some patients.

Zantac Lawsuit

Ongoing Claims

Litigation involving Zantac has focused on allegations tied to product safety, chemical contamination concerns, and serious disease claims depending on the case context.

Browse by Drug Category

GLP-1 & Metabolic Drugs

These claims often involve medications used for diabetes or weight management, where litigation may focus on severe gastrointestinal injury, delayed gastric emptying, bowel complications, or related harms.

OzempicWegovyMounjaro

Hearing, Vision & Neurologic Injury Claims

Some pharmaceutical claims involve alleged sensory or neurologic injury, including hearing damage, visual injury, neuropathy, or other serious complications.

TepezzaElmiron

Recalled Drugs & Safety Warning Cases

Some claims intensify after recalls, label changes, regulatory scrutiny, or broader public concern about previously underemphasized risks.

Zantac

Failure-to-Warn & Serious Adverse Event Claims

In many drug cases, the issue is not simply that a drug carried risk. It is whether users and prescribers were adequately warned about serious known or knowable risks.

How Dangerous Drug Cases Usually Arise

Drug cases often begin in one of four ways:

1

Severe Injury After Use

A patient takes a drug and later develops a major complication, such as organ injury, severe gastrointestinal dysfunction, cancer-related concerns, hearing loss, or visual damage.

2

A Safety Warning, Label Change, or Recall

A person learns after the fact that the medication has drawn significant regulatory, litigation, or safety attention.

3

A Pattern Emerges in Litigation

Even without a recall, broader lawsuits may reveal repeated allegations involving the same drug and similar injuries.

4

Medical Review Connects the Injury to the Drug

A treating physician, specialist, or later review raises concern that the medication may have contributed materially to the harm.

That does not automatically create a viable claim. The question is whether the injury fits a provable pharmaceutical liability theory.

What May Affect Whether You Have a Drug Claim

A stronger basis for review often includes several of the following:

Factors that may strengthen a claim
  • clearly documented use of the medication
  • a serious, medically recognized injury
  • a timeline that plausibly links drug exposure to the harm
  • records showing diagnosis, treatment, and resulting damages
  • a drug already associated with active litigation, investigation, or major warning changes
  • a viable theory such as inadequate warnings or product defect
  • damages substantial enough to justify litigation
Factors that may weaken a claim
  • vague or minor symptoms without clear medical documentation
  • weak or missing proof of product exposure
  • substantial alternative causes that may better explain the injury
  • limited medical support connecting the drug to the injury

The fact that something happened after a prescription was filled is not nothing. It is just not, by itself, the whole case.

Key Dangerous Drug Topics

How to Use This Resource

Scenario 1

If you know the drug name

Start with the medication-specific lawsuit page.

Scenario 2

If you know the injury but not the legal category

Browse by drug category, then use related litigation and resource pages to narrow the issue.

Scenario 3

If the drug was recalled or heavily warned about

Review both the recall-related page and the underlying lawsuit page. A recall may matter, but it does not answer every liability question by itself.

Scenario 4

If you are not sure whether you qualify

Start with the broader Dangerous Drug Lawyer page and then move to qualification or case-evaluation resources.

This section is meant to reduce confusion, not manufacture certainty where the facts do not support it.

Why MD Law Treats Dangerous Drugs as Their Own System

Drug claims are not simply "bad side effect" stories with a lawsuit stapled onto them. They often involve regulatory history, warning language, medical chronology, competing causes, scientific literature, adverse event patterns, and evolving litigation theories.

That is why MD Law treats dangerous drug claims as their own structured area within the platform. The goal is to help users understand:

  • what the drug is
  • what injuries are being alleged
  • what the current litigation status appears to be
  • what evidence and records may matter
  • how these claims are evaluated
  • what next step makes sense

That tends to be more useful than the usual legal internet ritual of repeating a drug name until search traffic falls from the ceiling.

Frequently Asked Questions

Start with the Drug, the Timeline, and the Injury Pattern

If you believe a prescription medication caused serious harm, begin by identifying the product, understanding the complication, and preserving the records that matter.

Structured. Serious. Built for medically and legally complex claims.